Potential use of aromatase inhibitors in gynecology

References

• Simpson ER, Davis SR. Mini-review: aromatase and the regulation of estrogen biosynthesis – some new perspectives. Endocrinology142, 4589–4594 (2001).
   PubMed Web of Science ®Google Scholar
• Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil. Steril.85, 277–284 (2006).
   PubMed Web of Science ®Google Scholar
• Simpson ER, Mahendroo MS, Means D et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev.15, 342–355 (1994).
   PubMed Web of Science ®Google Scholar
• Michael MD, Michael LF, Simpson ER. A CRE-like sequence that binds CREB and contributes to cAMP dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene. Mol. Cell Endocrinol.134, 147–156 (1997).
   Google Scholar
• Zhao Y, Mendelson CR, Simpson ER. Characterisation of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Mol. Endocrinol.9, 340–349 (1995).
   PubMed Web of Science ®Google Scholar
• Agarwal VR, Bulun SE, Leitch M, Rohrick R, Simpson ER. Use of alternative promotors to express the aromatase cytochrome P450 enzyme (CYP19) gene in breast adipose tissues of cancer free and breast cancer patients. J. Clin. Endocrinol. Metab.81, 3843–3849 (1996).
   PubMed Web of Science ®Google Scholar
• Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. J. Med. Chem.3, 2933–2944 (1990).
   Google Scholar
• Nabholtz JM, Buzdar A, Pollak M et al. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomised trial. Arimidex Study Group. J. Clin. Oncol.18, 3758–3767 (2000).
   PubMed Web of Science ®Google Scholar
• Colussi DM, Parisot CY, Lefevre GY. Plasma protein binding of letrozole, a new nonsteriodal aromatase enzyme inhibitor. J. Clin. Pharmacol.38, 727–735 (1998).
   PubMed Web of Science ®Google Scholar
• Pfister HC, Martoni A, Zamagni C et al. Effect of age and single versus multiple dose pharmacokinetics of letrozole in breast cancer patients. Biopharm. Drug Dispos.22, 191–197 (2001).
   PubMed Web of Science ®Google Scholar
• Haynes BP, Dowsett M, Miller WR, Dixon JM, Bhatnagar AS. The pharmacology of letrozole. J. Ster. Biochem. Mol. Biol.87, 35–45 (2003).
   PubMed Web of Science ®Google Scholar
• Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE. Influence of letrozole and anastrozole on total body aromatisation and plasma estrogen levels in post menopausal breast cancer patients evaluated in a randomised cross over study. J. Clin. Oncol.20, 751–757 (2002).
   PubMed Web of Science ®Google Scholar
• Evans TR, Di Salle E, Ornati G et al. Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor in postmenopausal women. Cancer Res.52, 5933–5939 (1992).
   PubMed Web of Science ®Google Scholar
• Geisler J, King N, Anker G et al. In vivo inhibition of aromatisation by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients. Clin. Cancer Res.4, 2089–2093 (1998).
   PubMed Web of Science ®Google Scholar
• Bonhoff AJ, Nether OG, Johannisson E. Effects of clomiphene citrate on endometrial structure in infertile women. Hum. Reprod.11, 844–849 (1996).
   PubMed Web of Science ®Google Scholar
• Gonan Y, Casper RF. Sonographic determination of an adverse effect of clomiphene citrate on endometrial growth. Hum. Reprod.5, 670–674 (1990).
   Google Scholar
• Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil. Steril.56, 465–468 (1991).
   PubMed Web of Science ®Google Scholar
• Weil S, Vondole K, Sou J, Boudy C. Androgen and follicle stimulating hormone interactions in primate ovarian follicle development. J. Clin. Endocrinol. Metab.84, 2951–2956 (1999).
   PubMed Web of Science ®Google Scholar
• Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomised double blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil. Steril.78, 280–285 (2002).
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Casper RF. Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod. Technol.10, 244–247 (2000).
   Google Scholar
• Mitwally MF, Casper RF. Use of an aromatase inhibitor for ovulation induction in patients with an inadequate response to clomiphene citrate. Fertil. Steril.75, 30530–30539 (2000).
   Google Scholar
• Cortinez A, De Carvalho I, Vantman D et al. Hormonal profile and endometrial morphology in letrozole controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil. Steril.83(1), 110–115 (2005).
   PubMed Web of Science ®Google Scholar
• Al-Omari WR, Sulman WR, Al-Hadithi N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int. J. Gynaecol. Obstet.85, 289–291 (2004).
   PubMedGoogle Scholar
• Sammour A, Biljan MM, Tan SL, Tulandi T. Prospective randomised trial comparing the effects of letrozole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination. Fertil. Steril.76(Suppl. 1), S110 (2001) (Abstract).
   Google Scholar
• Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotropin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum. Reprod.18, 1588–1597 (2003).
   PubMed Web of Science ®Google Scholar
• Healey S, Tan SL, Tulandi T, Biljan M. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil. Steril.80, 1325–1329 (2004).
   Google Scholar
• Al-Fadhli R, Sylvestre C, Buckett W, Tan SL, Tulandi T. A randomized trial of superovulation with two different doses of letrozole. Fertil. Steril.85, 161–164 (2006).
   PubMed Web of Science ®Google Scholar
• Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Oral presentation ASRM 2005. Fertil. Steril.84(Suppl. 1), 0–231 (2005).
   Google Scholar
• Tulandi T, Martin J, Al-Fadhli R et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil. Steril.85(6), 1761–1765 (2006).
   PubMed Web of Science ®Google Scholar
• Buttram VC, Reiter RC. Uterine myomata: etiology, symptomatology and management. Fertil. Steril.36, 433–445 (1981).
   PubMed Web of Science ®Google Scholar
• Stewart EA. Uterine fibroids. Lancet357, 293–298 (2001).
   PubMed Web of Science ®Google Scholar
• Felberbaum RE, Germer U, Ludwig M et al. Treatment of uterine fibroids with a slow release formulation of the gonadotropin releasing hormone antagonist Cetrorelix. Hum. Reprod.13, 660–668 (1998).
   Google Scholar
• De Leo V, Morgante G, Lanzetta D, D’Antona D, Bertieri RS. Danazol administration after gonadotropin releasing hormone analog reduces rebound of uterine myomas. Hum. Reprod.12, 357–360 (1997).
   Google Scholar
• Coutinho EM, Goncalves MT. Long term treatment of myomas with gestrinone. Fertil. Steril.51, 939–946 (1989).
   PubMed Web of Science ®Google Scholar
• Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS. Regression of uterine myomata in response to the antiprogesterone RU 486. J. Clin. Endocrinol. Metab.76, 513–517 (1993).
   PubMed Web of Science ®Google Scholar
• Sumitani H, Shozu T, Segawa HJ, Yang K, Murakami M. In situ estrogen synthesized by aromatase P450 in uterine myoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology141, 3852–3861 (2000).
   PubMed Web of Science ®Google Scholar
• Bulun SE, Simpson ER, Word RA. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human myoma tissues and cells in culture. J. Clin. Endocrinol. Metab.78, 736–743 (1994).
   PubMed Web of Science ®Google Scholar
• Shozu M, Murakami K, Segawa T, Kasai T, Inoue M. Successful treatment of symptomatic uterine myoma with a non-steroidal aromatase inhibitor in a premenopausal woman. Fertil. Steril.79, 628–631 (2003).
   PubMed Web of Science ®Google Scholar
• Vessey MP, Villard-Mackintosh L, Painter R. Epidemiology of endometriosis in women attending family planning clinics. Br. Med. J.306, 182–184 (1993).
   PubMed Web of Science ®Google Scholar
• Zeitoun K, Takayama K, Michael MD, Bulun SE. Stimulation of aromatase promoter II activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol. Endocrinol.13, 239–253 (1999).
   PubMed Web of Science ®Google Scholar
• Noble LS, Takayam K, Zeitoun KM et al. Prostaglandin stimulates aromatase expression in endometriosis derived stromal cells. J. Clin. Endocrinol. Metab.82, 600–606 (1997).
   PubMed Web of Science ®Google Scholar
• Bulun SE, Imir G, Utsunomiya H et al. Aromatase in endometriosis and uterine myomata. J. Steroid Biochem. Mol. Biol.95, 57–62 (2005).
   PubMed Web of Science ®Google Scholar
• Waller KG, Shaw RW. Gonadotropin-releasing hormone analogs for the treatment of endometriosis: long-term follow-up. Fertil. Steril.59, 511–515 (1993).
   PubMed Web of Science ®Google Scholar
• Bulun SE, Zeitoun K, Takayama K et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr. Relat. Cancer6, 293 (1999).
   PubMed Web of Science ®Google Scholar
• Takayama K, Zeitoun K, Gunby RT et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil. Steril.69, 709 (1998).
   PubMed Web of Science ®Google Scholar
• Razzi S, Fava A, Sartini A et al. Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman. BJOG111, 182–184 (2004).
   PubMed Web of Science ®Google Scholar
• Ailawadi RK, Jobanputra S, Kataria M et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil. Steril.81, 290–296 (2004).
   PubMed Web of Science ®Google Scholar
• Soysal S, Sysal ME, Ozer S, Gul N, Gezgin T. The effects of post-surgical administration of goserelin plus anastozole compared to goserelin alone in patients with severe endometriosis: a prospective randomised trial. Hum. Reprod.19, 160–167 (2004).
   PubMed Web of Science ®Google Scholar
• Simpson ER. Aromatase: biologic relevance of tissue-specific expression. Semin. Reprod. Med.22, 11–23 (2004).
   PubMed Web of Science ®Google Scholar